feed,title,long_url,short_url
SeekingAlpha,Rigel cutting 16% of workforce after declining to file sNDA for fostamatinib,https://seekingalpha.com/news/3890161,
SeekingAlpha,Why I Have A Hold Rating On Oracle,https://seekingalpha.com/article/4545758,
SeekingAlpha,Foghorn Therapeutics: Selling For Less Than Cash Value,https://seekingalpha.com/article/4545757,
